Blog
Pan-vaccine antigen technique confers safety in opposition to cross-clade SARS-CoV-2 variants, together with vaccine-resistant Omicron variants
06
Jan
Jan
In a current article revealed in Science Translational Drugs, researchers developed a novel pan-vaccine antigen (Span)-based subunit vaccine in opposition to coronavirus illness 2019 (COVID-19). Utilizing a mouse mannequin, in addition they demonstrated that this vaccine formulation conferred safety in opposition to a number of clades of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Research: […]